InvestorsHub Logo
Followers 15
Posts 1314
Boards Moderated 0
Alias Born 09/11/2007

Re: None

Saturday, 07/11/2020 7:39:06 PM

Saturday, July 11, 2020 7:39:06 PM

Post# of 42654
Lenzilumab, an engineered human IgG1 kappa monoclonal antibody, was associated with a clinical benefit in approximately one-third of patients with chronic myelomonocytic leukemia (#CMML) #leusm